South Korean Pharmaceuticals & Biotech Mid-Large Cap Stocks

PharmaResearch

Market Cap: ₩3.1t

Operates as a biopharmaceutical company primarily in South Korea.

Yuhan

Market Cap: ₩5.9t

Operates as a pharmaceutical company in South Korea and internationally.

Samsung BiologicsLtd

Market Cap: ₩63.4t

Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

Hanall Biopharma

Market Cap: ₩2.8t

A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.

SK bioscienceLtd

Market Cap: ₩3.2t

Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.

Samsung Epis Holdings

Market Cap: ₩11.3t

A biotechnology company, manage the portfolio of biopharmaceutical products.

D&D Pharmatech

Market Cap: ₩4.7t

Engages in the research and development and manufacturing of pharmaceuticals in South Korea.

L&C BIOLTD

Market Cap: ₩2.3t

Operates as a research and development company in tissue regeneration medicine.

Hanmi Pharm

Market Cap: ₩5.7t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

Oscotec

Market Cap: ₩1.6t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

NatureCellLtd

Market Cap: ₩2.1t

Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.

Peptron

Market Cap: ₩5.6t

Engages in the development of peptide-based medicines.

Mezzion PharmaLtd

Market Cap: ₩2.0t

Develops, manufactures, and sells pharmaceutical products in South Korea.

SK Biopharmaceuticals

Market Cap: ₩7.1t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

ALTEOGEN

Market Cap: ₩20.0t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

ABL Bio

Market Cap: ₩6.1t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

Hugel

Market Cap: ₩2.8t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

Celltrion Pharm

Market Cap: ₩2.0t

A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.

Celltrion

Market Cap: ₩38.4t

A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.

Aimed Bio

Market Cap: ₩1.8t

Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.

Sam Chun Dang Pharm

Market Cap: ₩6.4t

Engages in the manufacturing and sale of pharmaceutical products in South Korea.

ST PharmLtd

Market Cap: ₩2.8t

Provides manufacturing services for active pharmaceutical ingredient and intermediate.

Kolon TissueGene

Market Cap: ₩9.6t

Develops cell therapies for orthopedic diseases and other unmet medical needs.

Caregen

Market Cap: ₩3.9t

A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.

LigaChem Biosciences

Market Cap: ₩5.4t

A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.

OliX Pharmaceuticals

Market Cap: ₩2.9t

A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.

Voronoi

Market Cap: ₩3.9t

Researches, develops, and discovers small molecule kinase inhibitors in South Korea.